Nuo Therapeutics (CMXI) Gross Profit Margin starting from the second quarter 2026 to second quarter 2020, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Nuo Therapeutics, Inc.  (CMXI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Nuo Therapeutics's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CMXI Gross Profit Margin (Jun 30 2026)
Q2
(Jun 30 2021)
Q2
(Mar 31 2021)
Q1
(Dec 31 2020)
Q4
(Sep 30 2020)
Q3
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $1.77
Gross Profit Margin 66.14 %
Gross Profit Margin Total Ranking # 3737
Gross Profit In Millions $1.17
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin



Observing second quarter 2026 results within Medical Laboratories industry 20 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 3451 to 3737.
Learn about Gross Margin
CMXI's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 21
Healthcare Sector # 328
Overall # 2963

Gross Profit Margin Statistics
High Average Low
73.41 % 43.95 % 15.34 %
(Jun 30 2012)   (Sep 30 2013)




Other Gross Profit Margin Profitability Ratios
CMXI's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CMXI's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CMXI's Competitors
Gross Profit Margin Profit Margin for Nuo Therapeutics's Suppliers
Gross Profit Margin Profit Margin for CMXI's Customers

You may also want to know
CMXI's Annual Growth Rates CMXI's Profitability Ratios CMXI's Asset Turnover Ratio CMXI's Dividend Growth
CMXI's Roe CMXI's Valuation Ratios CMXI's Financial Strength Ratios CMXI's Gross Profit Growth
CMXI's Roa CMXI's Inventory Turnover Ratio CMXI's Growth Rates CMXI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Laboratories Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Veracyte Inc   98.18 %$ 147.580  Millions$ 150.321  Millions
Castle Biosciences Inc   77.11 %$ 79.846  Millions$ 103.546  Millions
Maxcyte inc   76.96 %$ 5.596  Millions$ 7.271  Millions
Butterfly Network Inc   71.41 %$ 23.288  Millions$ 32.612  Millions
Billiontoone Inc   70.45 %$ 77.107  Millions$ 109.448  Millions
Nuo Therapeutics, Inc.  66.14 %$ 1.170  Millions$ 1.769  Millions
Guardant Health Inc   65.39 %$ 219.029  Millions$ 334.978  Millions
Nrc Health  61.67 %$ 21.828  Millions$ 35.392  Millions
Exagen Inc   61.27 %$ 12.217  Millions$ 19.941  Millions
Ispecimen inc   45.18 %$ 0.069  Millions$ 0.152  Millions
Quest Diagnostics Inc  33.75 %$ 1,027.000  Millions$ 3,043.000  Millions
Aclarion Inc   32.93 %$ 0.008  Millions$ 0.025  Millions
Fulgent Genetics Inc   30.07 %$ 25.679  Millions$ 85.389  Millions
Labcorp Holdings Inc   29.80 %$ 1,112.000  Millions$ 3,731.100  Millions
Medpace Holdings Inc   28.51 %$ 201.637  Millions$ 707.331  Millions
Personalis Inc   21.21 %$ 4.743  Millions$ 22.357  Millions
Fortrea Holdings Inc   20.52 %$ 139.200  Millions$ 678.200  Millions
Bionexus Gene Lab Corp   17.05 %$ 0.013  Millions$ 0.076  Millions
American Shared Hospital Services  17.00 %$ 1.433  Millions$ 8.430  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.